Registry of gallbladder cancer patients in China

Chinese Research Group of Gallbladder Cancer

Observational Shanghai Jiao Tong University School of Medicine · NCT04140552

This study collects health information from gallbladder cancer patients in China to see how they are diagnosed and treated, aiming to improve care for future patients.

Quick facts

Study typeObservational
Enrollment10000 (estimated)
SexAll
SponsorShanghai Jiao Tong University School of Medicine Academic / other
Locations55 sites (Bengbu, Anhui and 54 other locations)
Trial IDNCT04140552 on ClinicalTrials.gov

What this trial studies

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a multicenter observational registry that collects electronic medical records from patients diagnosed with gallbladder cancer across various hospitals in China. The study aims to analyze current diagnostic and treatment practices, clarify the prognostic significance of various risk factors, improve staging accuracy, and standardize treatment protocols for gallbladder cancer. By compiling this data, the CRGGC seeks to enhance understanding and management of this condition within the Chinese healthcare context.

Who should consider this trial

Good fit: Ideal candidates for this study are patients with a confirmed clinical diagnosis of gallbladder cancer who have accessible electronic medical records.

Not a fit: Patients with undetermined primary sites of cancer will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis, treatment, and outcomes for patients with gallbladder cancer.

How similar studies have performed: While this approach is observational and builds on existing knowledge, similar studies have successfully contributed to advancements in cancer treatment and management.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer).
* Patients with accessible electronic medical record

Exclusion Criteria:

* Patients with undetermined primary site of cancer.

Where this trial is running

Bengbu, Anhui and 54 other locations

+5 more sites — see ClinicalTrials.gov for the full list.

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Gallbladder Neoplasmsgallbladder neoplasmsgallbladder cancer
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.